CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Sharp Therapeutics Corp is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Sharp Therapeutics Corp
2403 Sidney St, Suite 264
Phone: (412) 206-5303p:412 206-5303 PITTSBURGH, PA  15203  United States Ticker: SHRXSHRX
Business Summary
Sharp Therapeutics Corp. is a preclinical therapeutics company engaged in the discovery and development of small-molecule therapies for the treatment of genetic diseases. It uses a collection of platform technologies to discover compounds that can restore the function lost in mutation, thus restoring the patient to normality. The components of this technology platform are the CoreX assay technology, which enables measurements of the loss-of-function associated with gene mutation in a particular disease; the AlloChem Compound Libraries, that have been curated from commercial compound libraries for their ability to bind the target protein in an allosteric manner, thus increasing its stability and activity at the same time, and the Mine data system and machine learning layer, which combines data from various compounds and programs to provide models for what compounds should be made during medicinal chemistry and to improve the data quality of the signals coming from the CoreX assays.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202412/31/2023Yes----

Industries
SIC Code Description
6726 Unit investment trusts, face-amount certificate offices

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
President, Chief Executive Officer, Company Secretary, Director LorneSugarman 54 1/1/2023 10/4/2021
Chief Financial Officer EdwardJonasson 55 9/28/2022 9/28/2022
Independent Director JasonBaibokas 47 5/2/2023 5/2/2023
Independent Director MarkDickinson 50 11/30/2022 11/30/2022
Independent Director Jason D.Meretsky 55 10/4/2021 10/4/2021

Subsidiaries
Business Name Address City State/Province Country
Sharp Edge Labs, Inc. 2403 Sidney St. Pittsburgh PA United States

Business Names
Business Name
EVP.P
Sharp Edge Labs, Inc.
SHRX

General Information
Outstanding Shares: 8,545,200 (As of 9/30/2024)
Stock Exchange: CVE


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Monday, January 27, 2025